Project Grant 2136709

Award Date 4/15/22
Completion Date 3/31/23
Dollars Obligated $256K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Portland, OR 97201, USA
Similar Awards
Compact Medical Inc. received a $255,925 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop a novel respiratory bag-valve-mask resuscitator. The grant was awarded on August 15, 2021 under the NSF's Engineering program (CFDA #47.041) and will support product development activities through February 28, 2022. The Engineering program seeks to foster innovation in engineering research and education to improve quality of life and economic strength....
The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...
Singleto2 Therapeutics LLC received a $255,999 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation to develop safe disinfection and oxygen-level enrichment technologies for recirculating aquaculture systems using singlet oxygen. The grant was awarded on August 1, 2021 under the National Science Foundation's Engineering program (CFDA #47.041) to support innovation, creativity, and excellence in engineering research. The one-year project period will...
This $199,999 project grant from the Department of Energy Office of Science, under the Office of Science Financial Assistance Program (CFDA 81.049), funded the development of an OxyCycle membrane for high-purity oxygen separation from air. Luna Innovations Incorporated was awarded the funding on February 22, 2021 to develop the membrane technology with the goal of completing work by November 21, 2021. Under the award, Luna Innovations tasked sub-awardee Trimeric Corporation with evaluating...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,991 will enable Atmosense, Inc., a small, minority-owned business, to conduct R&D into optimized high surface area functionalized nanomaterials for parts per billion (PPB) gas sensing using machine learning models. The key objectives are to accelerate the development of candidate nanomaterials by integrating high-throughput synthesis and experiments with first...
GP Ionics LLC received a $255,400 Project Grant award from the National Science Foundation on March 15, 2021 to support work under the SBIR PHASE I: MULTI-STEP SEQUENTIAL PROCESSING OF GAS IONS FOR IDENTIFYING VOLATILE ORGANIC COMPOUNDS IN RECIRCULATED AIR OF ENERGY EFFICIENT BUILDINGS project. The funding period runs through February 28, 2023. The award is provided through the NSF's Technology, Innovation, and Partnerships program (CFDA #47.084), which seeks to advance science, engineering, and...
This federal Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program, totaling $274,274, supports the development of a novel extracorporeal respiratory dialysis system by X-Cor Therapeutics Inc., a minority-owned small disadvantaged business in Washington, D.C. The project aims to create an ultra-low-flow carbon dioxide removal system that can support extubation or avoid intubation for patients with chronic obstructive...
The Department of Energy Office of Science awarded Susteon Inc. a $200,000 Project Grant under the Office of Science Financial Assistance Program (CFDA 81.049) to develop a Modular Rapid PSA System for High Purity Oxygen Production. The grant had a period of performance from February 22, 2021 through November 21, 2021. As part of the award, Susteon delivered a modular pressure swing adsorption system to produce high purity oxygen. A sub-award of $50,000 was provided to the Georgia Tech...
Noble Gas Systems Inc. received a $255,946 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop conformable high pressure gas storage systems. Funded under the NSF's Engineering program (CFDA #47.041), the award supported the company's work from May 2021 through February 2022 to advance engineering research and innovation in enabling technologies for storing gases at high pressures in flexible containers. The NSF Engineering program seeks to...
The National Science Foundation (NSF) awarded Compact Medical Inc., a for-profit medical device manufacturer, a $999,931 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The funding supports the development and testing of a novel, adjustable bag-valve-mask (BVM) resuscitator device that allows emergency providers to deliver customized air volumes and pressures based on patient body size. This advanced resuscitator aims to address issues with...

This $256,000 National Science Foundation SBIR Phase I Project Grant to Airomatix, Inc. supports the development of a portable oxygen concentrator capable of producing breathable oxygen at higher flow rates than current models. The concentrator utilizes a novel photocatalytic reaction to separate oxygen from ambient air and store it in a chemical solution. It will then release oxygen on demand through a temperature-controlled reaction. During the one-year period of performance ending March 2023, the company will evaluate optimal conditions for the oxygen capture and release reactions using absorption spectroscopy. Several photosensitizer compounds will be tested to determine their effects on oxygen production and system longevity under higher temperatures and light exposure. The project aims to develop a prototype capable of generating targeted oxygen flow rates above 4 liters per minute at an efficient rate of energy consumption. Bench tests will validate the oxygen produced is safe for inhalation. This award supports the goals of the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to advance solutions for national challenges through innovative technologies.

Generated 1/6/24, 10:29 PM